Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis

Eur Respir J. 2011 Sep;38(3):730-3. doi: 10.1183/09031936.00195210.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / pharmacology*
  • Adult
  • Amikacin / administration & dosage
  • Antitubercular Agents / therapeutic use
  • Capreomycin / administration & dosage
  • Drug-Related Side Effects and Adverse Reactions
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Female
  • Fluoroquinolones / administration & dosage
  • Humans
  • Infectious Disease Medicine / methods
  • Isoniazid / administration & dosage
  • Kanamycin / administration & dosage
  • Linezolid
  • Male
  • Middle Aged
  • Oxazolidinones / pharmacology*
  • Rifampin / administration & dosage

Substances

  • Acetamides
  • Antitubercular Agents
  • Fluoroquinolones
  • Oxazolidinones
  • Capreomycin
  • Kanamycin
  • Amikacin
  • Linezolid
  • Isoniazid
  • Rifampin